The health division is likely to opt for a business-to-government (B-2-G) deal on the recommendations of the finance ministry instead of business-to-business (B-2-B) for import of China’s Sinopharm coronavirus vaccine.
B-2-G refers to the trade between a company (supplier) and a government (buyer). It is also known as a business-to-administration deal.
The finance ministry noted about the payments that 50 percent of the price may be paid through letter of credit (LC) before five days of shipment and the remaining would be paid after five days of receiving the vaccines.
Director General of Health Directorate Khurshid Alam said, “We need vaccines now as fast as we can make it. We are keeping in touch with China and Russia. Hopefully, vaccines from the two countries will be brought in soon.”